QuidelOrtho
QDEL
$39.76
Share price
-2.61%
Change (1 day)
-57.07%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
Earnings for QuidelOrtho (QDEL)
Earnings in 2023 (TTM): -$29.1 M
According to QuidelOrtho's latest financial reports the company's current earnings (TTM) are -$29.1 M. In 2022 the company made an earning of $0.73 B a decrease over its 2021 earnings that were of $0.90 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for QuidelOrtho from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$29.1 M | -103.95% |
| 2022 | $0.73 B | -18.27% |
| 2021 | $0.90 B | -13.45% |
| 2020 | $1.04 B | 1247.95% |
| 2019 | $77.17 M | 21.76% |
| 2018 | $63.38 M | -888.75% |
| 2017 | -$8.04 M | -50.39% |
| 2016 | -$16.2 M | 74.24% |
| 2015 | -$9.3 M | -15.35% |
| 2014 | -$10.99 M | -419.83% |
| 2013 | $3.43 M | -54.88% |
| 2012 | $7.61 M | -33.73% |
| 2011 | $11.48 M | -165.92% |
| 2010 | -$17.42 M | -133.4% |
| 2009 | $52.14 M | 75.18% |
| 2008 | $29.76 M | 45.04% |
| 2007 | $20.52 M | 36.55% |
| 2006 | $15.03 M | -382.15% |
| 2005 | -$5.33 M | -255.13% |
| 2004 | $3.43 M | -67.29% |
| 2003 | $10.49 M | 289.43% |
| 2002 | $2.69 M | -30.06% |
| 2001 | $3.85 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $6.29 B | -21,742.61% | 🇺🇸 USA |
 Becton Dickinson BDX | $1.54 B | -5,392.10% | 🇺🇸 USA |
 Danaher DHR | $5.33 B | -18,416.15% | 🇺🇸 USA |
 PerkinElmer
PKI | $0.47 B | -1,730.59% | 🇺🇸 USA |
 OraSure Technologies OSUR | $56.25 M | -293.33% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $55.5 M | -290.74% | 🇺🇸 USA |